Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950127-23-000021
Filing Date
2023-06-08
Accepted
2023-06-08 17:32:44
Documents
1
Period of Report
2023-05-29

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 4121
  Complete submission text file 0000950127-23-000021.txt   5750
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Issuer) CIK: 0001822691 (see all company filings)

EIN.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CALLE MANUEL POMBO ANGULO, 28 MADRID U3 28050
Business Address CALLE MANUEL POMBO ANGULO, 28 MADRID U3 28050 0034609314979
Insud Pharma S.L. (Reporting) CIK: 0001980616 (see all company filings)

State of Incorp.: U3 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39894 | Film No.: 231003094